Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adamantane - analogs & derivatives (1) 1
adamantane - therapeutic use (1) 1
adult (1) 1
analysis (1) 1
antitubercular agents - therapeutic use (1) 1
antituberculosis treatment (1) 1
articles (1) 1
bacterial infections and mycoses (1) 1
clinical trials (1) 1
combination (1) 1
communicable diseases (1) 1
consortia (1) 1
dosage and administration (1) 1
drug (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
drug therapy, combination (1) 1
drugstores (1) 1
ethambutol - therapeutic use (1) 1
ethylenediamines - therapeutic use (1) 1
female (1) 1
fluoroquinolones - therapeutic use (1) 1
humans (1) 1
index medicus (1) 1
infectious disease (1) 1
infectious diseases (1) 1
isoniazid - therapeutic use (1) 1
lung diseases (1) 1
male (1) 1
medical colleges (1) 1
moxifloxacin (1) 1
mycobacterium-tuberculosis (1) 1
pharmacokinetics (1) 1
pharmacy (1) 1
phase-ii (1) 1
public health (1) 1
pulmonary tuberculosis (1) 1
pyrazinamide - therapeutic use (1) 1
ra0421 public health. hygiene. preventive medicine (1) 1
ranging trial (1) 1
research institutes (1) 1
rifampin (1) 1
rifampin - therapeutic use (1) 1
solid culture (1) 1
south africa (1) 1
sputum (1) 1
studies (1) 1
tanzania (1) 1
treatment (1) 1
tuberculosis (1) 1
tuberculosis, pulmonary - diagnosis (1) 1
tuberculosis, pulmonary - drug therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
by Boeree, Martin J, PhD and Heinrich, Norbert, MD and Aarnoutse, Rob, PhD and Diacon, Andreas H, PhD and Dawson, Rodney, PhD and Rehal, Sunita, MSc and Kibiki, Gibson S, Prof and Churchyard, Gavin, Prof and Sanne, Ian, FRCP and Ntinginya, Nyanda E, MD and Minja, Lilian T, MD and Hunt, Robert D, BSc and Charalambous, Salome, PhD and Hanekom, Madeleine, PhD and Semvua, Hadija H, PhD and Mpagama, Stellah G, PhD and Manyama, Christina, MD and Mtafya, Bariki, MSc and Reither, Klaus, MD and Wallis, Robert S, Prof and Venter, Amour, NatDipMicr and Narunsky, Kim, MD and Mekota, Anka, PhD and Henne, Sonja, MSc and Colbers, Angela, PhD and van Balen, Georgette Plemper, PhD and Gillespie, Stephen H, Prof and Phillips, Patrick P J, PhD and Hoelscher, Michael, Prof and PanACEA Consortium and PanACEA consortium
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 39 - 49
Summary Background Tuberculosis is the world's leading infectious disease killer. We aimed to identify shorter, safer drug regimens for the treatment of... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | DRUG | INFECTIOUS DISEASES | SOLID CULTURE | PHARMACOKINETICS | SPUTUM | PULMONARY TUBERCULOSIS | PHASE-II | RANGING TRIAL | COMBINATION | ANTITUBERCULOSIS TREATMENT | Drug Administration Schedule | Humans | Tanzania | Fluoroquinolones - therapeutic use | Male | Tuberculosis, Pulmonary - drug therapy | Ethylenediamines - therapeutic use | Pyrazinamide - therapeutic use | Tuberculosis, Pulmonary - diagnosis | Adamantane - therapeutic use | Adult | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | South Africa | Drug Therapy, Combination | Ethambutol - therapeutic use | Adamantane - analogs & derivatives | Antitubercular Agents - therapeutic use | Medical colleges | Tuberculosis | Pharmacy | Communicable diseases | Lung diseases | Clinical trials | Drugstores | Dosage and administration | Research institutes | Rifampin | Public health | Moxifloxacin | Analysis | Studies | Consortia | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.